Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis

Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs), approved as glucose-lowering drugs for the treatment of type 2 diabetes, have also been shown to reduce body weight. An extensive Medline, Cochrane database, and Embase search for “exenatide,” “liraglutide,” “albiglutide,” “semaglutide,” and “lix...

Descripción completa

Detalles Bibliográficos
Autores principales: Monami, Matteo, Dicembrini, Ilaria, Marchionni, Niccolò, Rotella, Carlo M., Mannucci, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362858/
https://www.ncbi.nlm.nih.gov/pubmed/22675341
http://dx.doi.org/10.1155/2012/672658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362858/
https://www.ncbi.nlm.nih.gov/pubmed/22675341
http://dx.doi.org/10.1155/2012/672658

Ejemplares similares